Recent Advances in Research on Association of Type 2 Diabetes Patients and Dry Eye Disease
Sidra Hafeez1, Shafia Maryam2 and Maria Arif2*
1Faculty of Pharmacy(FoP), Hamdard University, Islamabad, Pakistan
2Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
*Corresponding Author: Maria Arif, Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan.
Received:
October 11, 2023; Published: November 25, 2023
Abstract
Dry eye disease is a condition with poor vision low tear production and redness of eye. It is caused by infection, environment, medication, age and diseases. Type 2 Diabetes is chronic metabolic disorder with high blood glucose level which leads to organ failure and death. Diabetes is caused by genetics, old age, obesity, unbalanced diet, hypertension e.t.c. Recent years have witnessed an increase in prevalence of dry eye disease in type 2 diabetes patient. The recent research on the positive correlation of these diseases is stated in this review.
Keywords: Dry Eye Disease; Type 2 Diabetes; Ophthalmology; Tear Quality
References
- Ajith T A. “Alpha‐lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes”. Clinical and Experimental Pharmacology and Physiology12 (2020): 1883-1890.
- Lyu Y., et al. “The effect of the duration of diabetes on dry eye and corneal nerves”. Contact Lens and Anterior Eye 4 (2019): 380-385.
- Mu P Y., et al. “PPARγ: the dominant regulator among PPARs in dry eye lacrimal gland and diabetic lacrimal gland”. International Journal of Ophthalmology6 (2020): 860.
- Muthiah M., et al. “Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis”. Annals of Hepatology1 (2023): 100762.
- Nadeem H., et al. “Association of dry eye disease with diabetic retinopathy”. Journal of College of Physicians and Surgeons Pakistan 5 (2020): 493-497.
- Parab A A and Thavare R B. “AN INSIGHT VISION THROUGH DRY EYE SYNDROME: A SURVEY-BASED STUDY” (2019).
- Stern M E., et al. “Dry eye as a mucosal autoimmune disease”. International Reviews of Immunology1 (2013): 19-41.
- Stevenson W., et al. “Dry eye disease: an immune-mediated ocular surface disorder”. Archives of Ophthalmology1 (2012): 90-100.
- Ting D S J and Ghosh S. “Acute corneal perforation 1 week following uncomplicated cataract surgery: the implication of undiagnosed dry eye disease and topical NSAIDs”. Therapeutic Advances in Ophthalmology 11 (2019): 2515841419869508.
- Wang S., et al. “Dry eye disease is more prevalent in children with diabetes than in those without diabetes”. Current Eye Research12 (2019): 1299-1305.
- Ward M F., et al. “Racial and ethnic differences in the association between diabetes mellitus and dry eye disease”. Ophthalmic Epidemiology5 (2019): 295-300.
- Yang Q., et al. “Meibum lipid composition in type 2 diabetics with dry eye”. Experimental Eye Research 206 (2021): 108522.
- Yazdani-ibn-Taz M K., et al. “Patient-reported severity of dry eye and quality of life in diabetes”. Clinical Ophthalmology (Auckland, NZ) 13 (2019): 217.
- Yellamelli A., et al. “Assessment of Tear Film Parameters in Patients with Type 2 Diabetes Mellitus”. Journal of Evolution of Medical and Dental Sciences (2023): 61-66.
- Zhang Z., et al. “Ocular surface microbiota in diabetic patients with dry eye disease”. Investigative Ophthalmology and Visual Science 12 (2021): 13-13.
- Arif M., et al. “Peroxisome Proliferator-Activated Receptor-α (PPARα) Expression in a Clinical Population of Pakistani Patients with Type 2 Diabetes and Dyslipidemia”. International Journal of Molecular Sciences 18 (2022): 10847.
- Noh M H., et al. “APX 115A, a pan NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ induced diabetic rat model”. Experimental and Therapeutic Medicine5 (2023): 1-9.
Citation
Copyright